The Company also wishes to announce that it has granted options to acquire an aggregate of 840,000 common shares at a price of $2.25 per share for a period of five years to directors, officers, consultants and employees of the Company. The above grant is subject to regulatory approval, including the approval of the TSX Venture Exchange.